A Phase 3, Randomized, Double Blind, Double-Dummy, Multicenter, Parallel Group Comparison Study to on Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Comparing With AG-1749 in Patients With Duodenal Ulcer.
Phase of Trial: Phase III
Latest Information Update: 27 Nov 2016
At a glance
- Drugs Vonoprazan (Primary) ; Lansoprazole
- Indications Duodenal ulcer
- Focus Registrational; Therapeutic Use
- Sponsors Takeda
- 27 Nov 2016 Primary endpoint (Endoscopic Healing Rate of Duodenal Ulcer Over 6 Weeks) has not been met according to the results published in the Alimentary Pharmacology and Therapeutics.
- 27 Nov 2016 Results published in the Alimentary Pharmacology and Therapeutics.
- 12 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.